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Abstract 
A Brazilian-Portuguese translation of the MCMI-III (BP-MCMI-III) was developed to be used in Brazil and with the increasing 
population of Brazilian immigrants in the United States. This paper reports the results of a study that examined the diagnostic
validity of the BP-MCMI-III Alcohol Dependence and Drug Dependence scales for identifying substance-related problems 
among Brazilians. Findings support the scales’ validity.
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1. Purpose of the Study 
The Millon Clinical Multiaxial Inventory, third edition (MCMI-III: Millon, Davis, & Millon, 1994, 1997), is a 
personality inventory that is widely used in the United States and in many other countries to assess psychopathology 
in a variety of clinical settings (Craig, 2005). The instrument is considered to be well-designed and psychometrically 
stable, and to have several advantages over similar personality tests currently available (Groth-Marnat, 2003). The 
MCMI-III is relatively brief (compared to other personality inventories), easy to administer and score, and uses 
terminology that is similar to that used in the current Diagnostic Statistical Manual of Mental Disorders (DSM-IV-
TR: APA, 1994) (Choca & Van Denburg, 1997; Craig, 1997).  
Due to the instrument’s recognized clinical utility, a Brazilian-Portuguese translation of the MCMI-III (BP-
MCMI-III) was developed to be used in Brazil and with the increasing population of Brazilian immigrants in the 
United States. The initial phases of this project involved the completion of four preliminary steps in cross-cultural
test adaptation: (1) the translation phase, which included a series of procedures used to maximize translation 
accuracy and readability; (2) a pilot test-retest study, which evaluated item equivalency using a bilingual sample; (3) 
the revision phase, which involved further refinement of problem-items; and (4) a reliability study, which evaluated 
the psychometric properties of the new version with data collected in Brazil. The results of these studies were 
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encouraging and suggest that the translated instrument is psychometrically reliable and comparable to the original 
test (Magalhaes, 2005).
This paper presents the results of a study that examined the diagnostic validity of the BP-MCMI-III Alcohol 
Dependence and Drug Dependence scales with a Brazilian sample composed of clinical and non-clinical participants. 
The diagnostic validity of these scales was studied by comparing participants’ group status (patients receiving 
substance abuse treatment versus controls) against diagnoses made on the basis of the test (Hypothesis 1 and 
Hypothesis 2), and by comparing diagnoses made on the basis of the DSM-IV-TR against diagnoses made on the basis 
of the test (Hypothesis 3 and 4). In addition, the construct validity of the Alcohol Dependence scale was examined by 
comparing the participants’ scores on the BP-MCMI-III against scores on the Alcohol Use Disorders Identification 
Test (Hypothesis 5). Because the investigators did not find a measure of drug abuse/dependence in Portuguese that 
could be used in this study, the construct validity of the Drug Dependence scale was not tested. Post hoc analyses were 
conducted to estimate validity indices for both scales.   
2. Method 
2.1. Participants 
The sample utilized in this study (N=126) was composed of participants receiving treatment for substance-related 
disorders (clinical participants) and controls (non-clinical participants). Clinical participants (N=75) were contacted 
through two substance abuse treatment facilities in Rio de Janeiro, Brazil. Twenty-three were receiving treatment 
due to alcohol related disorders only, twelve due to drug related disorders only, and forty had diagnoses of both 
alcohol and drug related problems. Clinical participants were mostly male, single, unemployed, and Catholic. 
Approximately sixty-three percent had completed a minimum of 8th grade level education. Patients’ age ranged from 
18 to 60 years (M = 37; SD = 10).
Non-clinical participants were recruited through two churches in Rio de Janeiro, Brazil, via local contacts (a 
convenience sample). The non-clinical sample was composed of thirty-three female and eighteen male participants 
(N=51), with ages ranging from 19 to 67 years (M = 34; SD = 13). Most non-clinical participants identified 
themselves as Protestant, were either single or married, and had completed a minimum of 8th grade education. 
Approximately fifty percent had either college or graduate degrees. Regarding occupation, only six percent were 
unemployed.  
2.2. Instrumentation 
All participants were administered the following assessment measures: (1) the BP-MCMI-III, (2) the Alcohol Use 
Disorders Identification Test (AUDIT), (3) a diagnostic questionnaire (DQ), and (4) a demographic questionnaire. 
Testing was done typically in groups of 5 to 10 participants and subjects were administered the assessment materials 
in counterbalanced order to control for possible order effects. Approximately half of the sample completed the 
assessment measures in the following order: demographic questionnaire, BP-MCMI-III, DQ, and AUDIT. The other 
half completed the assessment measures in the following order: demographic questionnaire, DQ, AUDIT, and BP-
MCMI-III.  
2.2.1. The BP-MCMI-III Alcohol Dependence and Drug Dependence Scales  
Like the original MCMI-III, the BP-MCMI-III is a paper and pencil inventory containing 175 true-false items and 
a total of 27 subscales: (a) 3 for estimating the individual’s test-taking attitude, (b) 14 for measuring different 
personality styles, and (c) 10 for assessing the presence of clinical syndromes, including anxiety, depression, 
psychotic disorders, posttraumatic stress, and substance-related problems (Millon, Davis, & Millon, 1997). High 
scores on the Alcohol Dependence scale are expected to be indicative of current problematic drinking or a history of 
alcoholism with associated symptoms such as subjective distress, family problems, and deficits in social and 
occupational functioning. Similarly, high scores on the Drug Dependence scale are expected to be indicative of 
current drug use or a history of drug addiction with associated symptoms (Craig, 1993, 2005). A reliability study 
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with 220 Brazilian college students in Rio de Janeiro found test-retest coefficients of .70 and .85 for the BP-MCMI-
III Alcohol Dependence and Drug Dependence scales, respectively (Magalhaes, 2005).   
2.2.2. The Diagnostic Questionnaire  
Structured diagnostic interviews are commonly used in substance abuse research and are generally considered 
reliable instruments for use with both clinical samples and the general population (Grant and Towle, 1990; Grant, 
1997). The diagnostic questionnaire (DQ) used in this study was a reduced version of the Alcohol Use Disorder and 
Associated Disabilities Interview Schedule (AUDADIS), one of the most widely used diagnostic instruments of this 
type. The AUDADIS operationalized the DSM-IV criteria for alcohol abuse and dependence and relies exclusively 
on respondent self-report (Grant & Hasin, 1992). A study with the AUDADIS found the combined diagnoses of 
lifetime alcohol abuse and dependence to be highly reliable (Grant, Harford, Dawson, Chou, & Pickering, 1995). 
The reduced version used in this study was a self-report symptom checklist that contained 11 “yes-no” questions 
about substance use patterns, each corresponding to a specific diagnostic criterion listed under the DSM-IV-TR 
diagnostic code. Separate forms for alcohol and drug abuse/dependence were available. 
The translation of this instrument to Portuguese was completed by the first author, with the assistance of a 
professional translator. The translated version was back translated to English by a bilingual research assistant 
(Brazilian native) and compared with the original version by a monolingual English speaker (American native).  No 
major discrepancies were found between the two English versions and only minimal changes were made on the final 
Portuguese version that was used in this study. Diagnoses made on the basis of this questionnaire were compared 
against diagnoses made on the basis of the BP-MCMI-III to test hypotheses 3 and 4 and to calculate diagnostic 
efficiency indices for both substance dependence scales of the BP-MCMI-III.  
2.2.3. The Alcohol Use Disorders Identification Test 
The Alcohol Use Disorders Identification Test (AUDIT) was developed by the World Health Organization 
(WHO) in a six-country collaborative project for early detection of problem drinking, as part of a brief intervention 
trial (Saunders & Aasland, 1987). Unlike the MCMI-III Alcohol Dependence scale, which assesses drinking 
problems in the context of general psychopathology, the AUDIT was developed specifically for the detection of 
problem drinking in primary care settings, where hazardous drinkers seek medical treatment for other health-related 
concerns (Saunders, Aasland, Babor, De La Fuente, & Grant, 1993; Miles, Winstock, & Strang, 2001; Maisto, S. A., 
Conigliaro, J., McNeil, M., Kraemer, K., & Kelley, M. E., 2000; Allen, Litten, Fertig, & Babor, 1997; Fleming, 
Barry, & MacDonald, 1991).  
The AUDIT is a paper and pencil “yes-no” questionnaire composed of 10 items related to alcohol consumption 
patterns – three questions on the amount and frequency of drinking, three questions on harmful use of alcohol, and 
four on alcohol-related consequences – and with scores ranging from 0 to 40. In a review of the AUDIT literature, 
Reinert and Allen (2002) reported that the instrument has proven to be internally consistent with diverse samples 
and in different settings, with median Chronbach’s alpha falling in the .80s for the 18 studies included in the review. 
The four studies that tested the temporal reliability of the AUDIT over a two-week interval found results ranging 
from .64 to .92. The median sensitivity was .86 and the median specificity was .89 for a cut-off score of 8, across 13 
studies.  
The AUDIT translation used in this study was developed by a research team in São Paulo, Brazil, in collaboration 
with the WHO and researchers associated with the University of Connecticut under the leadership of Thomas Babor, 
one of the principal investigators involved in the development of the original instrument in English (Furtado, 2004). 
Although data to support the reliability and validity of this translation were not available at the time this study was 
conducted, data obtained with a similar translation offered support for the test’s validity for detecting alcohol related 
problems in the Brazilian population (Méndez, 1999). Méndez’ findings were obtained with a sample composed of 
733 participants recruited through two primary care facilities in Pelotas, Brazil. For a cut-off score of 8, sensitivity 
was .92 and specificity was .62. 
Despite the lack of new validity data to support the revised translation, five factors influenced the authors’ 
decision to use Furtado’s version in this study: (1) it was developed in collaboration with the original developers of 
the test, (2) it was up-to-date with the most current AUDIT manual, (3) the wording of the questions was more 
casual and more appropriate for the location where the data were collected, (4) items were adapted to account for 
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differences in the amount of alcohol contained in typical Brazilian drinks, and (5) cut-off scores were not needed for 
analysis (total scores were used).
2.2.4. The Demographic Questionnaire 
A demographic questionnaire was used to gather information about the participants’ age, gender, marital status, 
education, religion, occupation, history of substance abuse treatment, and reason for current admission to a 
substance abuse treatment facility. Information obtained with this questionnaire provided a description of the sample 
and determined group eligibility for hypotheses 1 and 2.
2.3. Clinical and Control Groups 
The composition of clinical and control groups varied for hypotheses 1, 2, 3, and 4. For testing hypothesis 1, the 
clinical group was composed of participants who were receiving treatment at the time of testing for alcohol-related 
problems only and those who were receiving treatment for both alcohol- and drug-related problems (N = 63). The 
control group was composed of non-clinical participants (N = 51). For hypothesis 2, the clinical group was 
composed of participants who were receiving treatment at the time of testing for drug-related problems only and 
those who were receiving treatment for both alcohol- and drug-related problems (N = 52); the control group was 
composed of non-clinical participants (N = 51). For hypothesis 3, the clinical group was composed of participants 
who were identified as having either an alcohol abuse or an alcohol dependence diagnosis according to DSM-IV-TR 
criteria (N = 66); the control group was composed of participants who did not meet DSM-IV-TR criteria for alcohol-
related disorders (N = 60). For hypothesis 4, the clinical group was composed of participants who were identified as 
having either a drug abuse or a drug dependence diagnosis according to DSM-IV-TR criteria (N = 72); the control 
group was composed of participants who did not meet DSM-IV-TR criteria for drug-related disorders (N = 54).
Group equality was tested by performing chi-square tests on the following variables: gender, marital status, 
occupation, education, religion, alcohol treatment history, drug treatment history, and frequency of drinking. A t-test 
was used for testing equality in terms of age. Clinical and control groups were found to be (a) non-equivalent on all 
demographic variables, except age, for hypothesis 1; (b) non-equivalent on all variables, except age, for hypothesis 
2; (c) non-equivalent on all variables, except marital status, for hypothesis 3; and (d) non-equivalent on all variables, 
except age, for hypothesis 4.
3. Results 
3.1. Hypotheses Testing 
For testing hypotheses 1, 2, 3 and 4, eight analyses of covariance (ANCOVAs) were run using gender, education, 
history of alcohol treatment, history of drug treatment, frequency of drinking, and dummy coded variables for 
marital status (1 = married; 0 = other) and religion (1 = Protestant; 0 = other) as covariates. The independent 
variables for each analysis were dichotomous (two groups = clinical, control) and the dependent variables were the 
raw and base rate scores for the Alcohol Dependence and Drug Dependence scales. Hypothesis 5 was tested by 
performing a t-test to determine the significance of the correlation between AUDIT scores and BP-MCMI-III scores.  
3.1.1. Hypothesis 1  
It was expected that clinical participants would have a significantly higher raw and base rate score than controls 
on the Alcohol Dependence scale when clinical and control groups were defined based on whether individuals were 
receiving or not receiving treatment for alcohol-related problems at the time of testing. The diagnostic validity of the 
Alcohol Dependence scale was supported by the results of the ANCOVAs when both raw (F = 18.19; df = 1, 111; p
< .05) and base rate scores (F = 7.79; df = 1, 111; p < .05) were used in the analyzes. The scores of patients 
receiving treatment for alcohol-related problems at the time of testing (N = 60) were significantly higher than the 
scores of non-clinical participants (N = 51). The magnitude of the effect (partial eta squared) reached .15 for raw and 
.07 for base rate scores.   
1486  Cristina Magalhães et al. / Procedia Social and Behavioral Sciences 5 (2010) 1482–1489
3.1.2. Hypothesis 2  
It was expected that clinical participants would have a significantly higher raw and base rate score than controls 
on the Drug Dependence scale when clinical and control groups were defined based on whether individuals were 
receiving or not receiving treatment for drug-related problems at the time of testing. The diagnostic validity of the 
Drug Dependence scale was also supported by the results of the ANCOVAs when both raw (F = 70.38; df = 1, 99; p
< .05) and base rate scores (F = 23.51; df = 1, 99; p < .05) were used in the analyzes. The scores of patients 
receiving treatment for drug-related problems (N = 48) were significantly higher than the scores of non-clinical 
participants (N = 51). The magnitude of the effect (partial eta squared) reached .44 for raw and .21 for base rate scores.  
3.1.3. Hypothesis 3 
For hypothesis 3, groups were defined based on the presence of positive (clinical) versus negative (control) 
DSM-IV-TR diagnoses. Participants who gave 3 or more “yes” responses for items 1 through 7 of the DQ (alcohol 
use questions) met the DSM-IV-TR diagnostic criteria for alcohol dependence; those who gave 1 or more “yes” 
responses for items 8 through 11 met criteria for alcohol abuse. It was expected that individuals diagnosed with 
alcohol abuse or dependence based on DSM-IV-TR criteria would have significantly higher raw and base rate scores 
than controls on the BP-MCMI-III Alcohol Dependence scale. 
The diagnostic validity of the BP-MCMI-III Alcohol Dependence scale was supported by the results of the 
ANCOVAs when group eligibility was defined by the presence of positive versus negative DSM-IV-TR diagnoses, 
for both raw (F = 10.24; df = 1, 121; p < .05) and base rate scores (F = 6.98; df = 1, 121; p < .05). Participants who 
scored positive for alcohol-related problems on the DQ obtained higher raw and base rate scores on the BP-MCMI-
III Alcohol Dependence scale than those who scored negative on the DQ. The magnitude of the effect (partial eta 
squared) reached .08 for raw and .06 for base rate scores.  
3.1.4. Hypothesis 4 
For hypothesis 4, groups were also defined based on the presence of positive (clinical) versus negative (control) 
DSM-IV-TR diagnoses. Participants who gave 3 or more “yes” responses for items 1 through 7 of the DQ (drug use 
questions) met the DSM-IV-TR diagnostic criteria for drug dependence; those who gave 1 or more “yes” responses 
for items 8 through 11 met criteria for drug abuse. It was expected that individuals diagnosed with drug abuse or 
dependence based on DSM-IV-TR criteria would have a significantly higher raw and base rate score than controls on the 
BP-MCMI-III Drug Dependence scale. 
The diagnostic validity of the BP-MCMI-III Drug Dependence scale was supported by the results of the 
ANCOVAs when group eligibility was defined by the presence of positive versus negative DSM-IV-TR diagnoses, 
for both raw (F = 61.83; df = 1, 121; p < .05) and base rate scores (F = 22.99; df = 1, 121; p < .05). Participants who 
scored positive for drug-related problems on the DQ obtained higher raw and base rate scores on the BP-MCMI-III 
Drug Dependence scale than those who scored negative on the DQ. The magnitude of the effect (partial eta squared) 
reached .36 for raw and .17 for base rate scores.  Table 1 summarizes the results of the ANCOVAs for hypotheses 1 
through 4.  
3.1.5. Hypothesis 5 
It was expected that there would be a significant positive correlation between subjects’ scores on the BP-MCMI-
III Alcohol Dependence scale and scores on the AUDIT. Pearson correlations between the AUDIT and the BP-
MCMI-III Alcohol Dependence scale were obtained using both raw (r = .81) and base rate scores (r = .72). The 
results showed strong positive correlations that were significant at the .01 level. Findings indicate that these two 
scales are measuring similar constructs and support the construct validity of the BP-MCMI-III Alcohol Dependence 
scale. 
3.2. Post Hoc Analyses 
Diagnostic validity indices were computed for the BP-MCMI-III Alcohol Dependence and Drug Dependence 
scales at cut-offs of 75, 80 and 85. The presence of positive versus negative DSM-IV-TR diagnoses, determined by 
the subjects’ scores on the DQ, was considered the “gold standard” to which diagnoses made by the BP-MCMI-III 
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were compared. As they apply to the clinical syndrome scales, cut-off scores of 75 and above on the MCMI-III 
indicate the presence of a syndrome; while scores of 85 and above indicate the prominence of a syndrome.  
At the cut-score of 75, the BP-MCMI-III alcohol and drug dependence scales performed approximately equal or 
better than the MCMI-III (at cut-score of 85) for most validity indices when the 1994 MCMI-III data set was used 
for comparison (Hsu, 2002; Restlaff, 1996). The BP-MCMI-III alcohol and drug dependence scales performed 
approximately equal or somewhat worse than the MCMI-III (at cut-score of 85) for most validity indices when the 
1997 MCMI-III data set was used for comparison (Hsu, 2002; Millon, Davis, & Millon, 1997). These results are not 
surprising given the fact that there is concern about the possibility of underestimation of the validity of the MCMI-
III based on the 1994 validity data and the potential for overestimation based on the 1997 data set (Hsu, 2002). 
Tables 2 and 3 present validity indices for the MCMI-III (at cut-score of 85) and the BP-MCMI-III (at 75 and 85 
cut-offs).
4. Discussion 
All hypotheses were supported by the data. Clinical participants scored significantly higher than non-clinical 
participants in both the alcohol dependence and drug dependence scales when group membership was determined 
based on participants’ treatment/no treatment status (hypotheses 1 and 2) and when determined based on the 
presence/absence of DSM-IV-TR diagnoses (hypotheses 3 and 4). Additionally, significant positive correlations 
were found between raw and base rate scores on the BP-MCMI-III alcohol dependence scale and the AUDIT. 
Diagnostic validity indices obtained with the present sample provided information on the diagnostic efficiency of 
the BP-MCMI-III substance dependence scales for detecting alcohol- and drug-related disorders among Brazilians. 
4.1. Internal and External Validity of the Study 
Potential threats to internal validity (associated with group differences in terms of gender, marital status, 
education, religion, history of alcohol treatment, history of drug treatment and frequency of drinking) were 
addressed with the use of ANCOVAs during hypotheses testing. Although ANCOVAs can not completely remove 
the potential for selection bias with intact groups, this method is considered to be a reasonable solution for the 
problem of unequal groups if caution is exercised when interpreting the results (Stevens, 1990). Given the 
limitations of ANCOVAs for controlling the potential for selection bias in non-randomized studies, the conclusions 
about this study are presented tentatively. 
The fact that the sample was composed of Brazilians residing in Brazil is one of the strengths of this study. If 
data had been collected in the United States, the participants’ understanding of individual test items potentially 
would have been affected by acculturation, which in turn would have limited the external validity of the results. 
Nevertheless, the results of this study must be interpreted in the context of the characteristics of the sample it used. 
Participants were recruited from low-income and middle-income suburban areas in Rio de Janeiro, the second 
largest metropolitan region in Brazil. Although it is unlikely that Brazilians residing in other parts of Brazil would 
have responded differently to the assessment measures, it is possible that regional differences in the use of the 
Portuguese language may have affected the results.
4.2. Future Directions 
This study represents the first validity study with the BP-MCMI-III. Findings supported the validity of the BP-
MCMI-III substance dependence scales for detecting substance-related problems among Brazilians. Future studies 
should focus on examining the diagnostic efficiency of the scales with a sample that includes a more heterogeneous 
psychiatric population so that new base rates can be computed. The validity of other BP-MCMI-III scales should be 
examined so that the instrument’s overall diagnostic utility can be ascertained. 
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5. Tables 
UTable 1. Results of the ANCOVAs for Hypotheses 1 through 4
F P η㼽
Hypotheses Raw Scores Base Rates Raw Scores Base Rates Raw Scores Base Rates 
Hypothesis 1 18.19 7.79 .000 .006 .15 .07 
Hypothesis 2 70.38 23.51 .000 .000 .44 .21 
Hypothesis 3 10.24 6.98 .002 .009 .08 .06 
Hypothesis 4 61.83 22.99 .000 .000 .36 .17 
UTable 2. Comparative Table of Validity Indices for the MCMI-III and the BP-MCMI-III Alcohol Dependence Scale
MCMI-III BP-MCMI-III
Validity Indices 1994a 1997a BR 75 BR 85 
Sensitivity .73** .80* .94 .71 
Specificity .86** .82 .93 
Positive Predictive Power .42** .88* .85 .92 
Negative Predictive Power .96** .93 .75 
Overall Diagnostic Power .88 .82 
Incremental Validity of Positive Test Diagnoses .30*** .71*** .33 .40 
Incremental Validity of Negative Test Diagnoses .08*** .13*** .41 .23 
Cohen’s Kappa .45*** .81*** .76 .64 
Prevalence .12** .17* .52 .52 
Effect Size 1.68*** 2.85*** 1.89 1.89 
Area Under Curve (AUC) .88*** .98*** .94 .94 
aStatistic calculated using cut-score of 85. 
*In Millon, Davis, & Millon, 1997; **In Restlaff, 1996; and ***In Hsu, 2002. 
UTable 3. Comparative Table of Validity Indices for the MCMI-III and the BP-MCMI-III Drug Dependence Scale
MCMI-III BP-MCMI-III
Validity Indices 1994 a 1997 a BR 75 BR 85 
Sensitivity .52** .82* .82 .65 
Specificity .95** .88 .95 
Positive Predictive Power .47** .93* .83 .90 
Negative Predictive Power .96** .87 .78 
Overall Diagnostic Power .85 .82 
Incremental Validity of Positive Test Diagnoses .39*** .82*** .41 .47 
Incremental Validity of Negative Test Diagnoses .04*** .09*** .44 .36 
Cohen’s Kappa .47*** .86*** .69 .62 
Prevalence .08** .11* .43 .43 
Effect Size 1.67*** 3.34*** 1.90 1.90 
Area Under Curve (AUC) .88*** .99*** .94 .94 
aStatistic calculated using cut-score of 85. 
*In Millon, Davis, & Millon, 1997; **In Restlaff, 1996; and ***In Hsu, 2002. 
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